The time course of the change in antibody titres in herpes gestationis

British Journal of Dermatology

Volumn 140, Issue 1, 1999, Pages 119-123

  Satoh, S ^a   Seishima, M ^a   Sawada, Y ^a   Izumi, T ^a   Yoneda, K ^b   Kitajima, Y ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Gifu Municipal Hospital   (Japan)

Author keywords

Antibody titres; Basement membrane zone; Direct immunofluorescence; Herpes gestationis

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G; MINOCYCLINE; PREDNISOLONE;

ADULT; ANTIBODY TITER; ARTICLE; BASEMENT MEMBRANE; CASE REPORT; COMPLEMENT DEPOSITION; DELIVERY; ERYTHEMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN DEPOSITION; ORAL DRUG ADMINISTRATION; PEMPHIGOID GESTATIONIS; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; TIME;

ADULT; ANTI-BACTERIAL AGENTS; AUTOANTIBODIES; AUTOANTIGENS; CARRIER PROTEINS; COLLAGEN; CYTOSKELETAL PROTEINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MINOCYCLINE; NERVE TISSUE PROTEINS; NON-FIBRILLAR COLLAGENS; PEMPHIGOID GESTATIONIS; PREGNANCY; PUERPERAL DISORDERS; TREATMENT OUTCOME;

EID: 0032974978     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02619.x     Document Type: Article

References (24)

1. Bushkell LL. Herpes gestationis, new immunologic findings. Arch Dermatol 1974; 11: 65-9.
2. Shomick JK, Bangert JL, Freeman RG, Gilliam JN. Herpes gestationis: Clinical and histologic features of twenty-eight cases. J Am Acad Dermatol 1983; 8: 214-24.
3. Marrison LH, Labib RS, Zone SS et al. Herpes gestationis autoantibodies recognize a 180-kD human epidermal antigen. J Clin Invest 1988; 81: 2023-6.
4. Diaz LA, Ratrie H, Saunders WS et al. Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. J Clin Invest 1990; 86: 1088-94.
5. Giudice GJ, Emery DJ, Diaz LA. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP 180. J Invest Dermatol 1992; 99: 243-50.
6. Giudice GJ, Emery DJ, Zelickson BD et al. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol 1993; 151: 5742-50.
7. Guidice GJ, Wilske KC, Anhalt GJ et al. Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis. J Invest Dermatol 1994; 102: 878-81.
8. Matsumura K, Amagai M, Nishikawa T, Hashimoto T. Majority of bullous pemphigoid and herpes gestationis sera react with NC16a domain of the 180 kD bullous pemphigoid antigen. Arch Dermatol Res 1996; 288: 507-9.
9. Lui Z, Diaz LA, Troy JL et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 1993; 92: 2480-8.
10. Kitajima Y, Hiraku Y, Owaribe K, Yaoita H. A possible cell-biologic mechanism involved in blister formation of bullous pemphigoid: anti-180-kD BPA antibody is an initiator. Dermatology 1994; 189 (Suppl. 1): 46-9.
11. Kitajima Y. Adhesion molecules in the pathophysiology of bullous diseases. Eur J Dermatol 1996; 6: 399-405.
12. Kitajima Y, Nojiri M, Yamada T et al. Internalization of the 180-kD bullous pemphigoid antigen as immune complexes in basal keratinocytes: An important early event in blister formation in bullous pemphigoid. Br J Dermatol 1998; 138: 71-6.
13. Hirose M, Akiyama LH, Ichiki Y et al. Herpes gestationis: Time course of the change in antibody titer after abortion. Eur J Dermatol 1997; 7: 134-6.
14. Nojiri M, Seishima M, Hirose M et al. Immunofluorescence and immunoblot studies of herpetiform pemphigus. Eur J Dermatol 1996; 6: 406-8.
15. Satoh S, Seishima M, Izumi T et al. A vesicular variant of bullous pemphigoid with autoantibodies against unidentified 205- and 150-kDa proteins at the basement membrane zone. Br J Dermatol 1997; 137: 768-73.
16. Holmes RC, Black MM. The specific dermatoses of pregnancy. J Am Acad Dermatol 1985; 8: 405-12
17. Shornick JK, Black MM. Fetal risk in herpes gestationis. J Am Acad Dermatol 1992; 26: 63-8.
18. Black MM. New observations on pemphigoid 'herpes' gestationis. Dermatology 1994; 189 (Suppl. 1): 50-1.
19. Kelly SE, Bhogal BS. Wojnarowska F et al. Western blot analysis of the antigen in pemphigoid gestationis. Br J Dermatol 1990; 122: 445-9.
20. Ghohestani R, Nicolas JF, Kanitakis J et al. Pemphigoid gestationis with autoantibodies exclusively directed to the 230 kDa bullous pemphigoid antigen (BP230 Ag). Br J Dermatol 1996; 134: 603-4.
21. Kirtschig G, Collier PM, Emmerson RW, Wojnarowska F. Severe case of pemphigoid gestationis with unusual target antigen. Br J Dermatol 1994; 131: 108-11.
22. Baxi LV, Kovilam OP, Collins MH, Walther RR. Recurrent herpes gestationis with postpartum flare: A case report. Am J Obstet Gynecol 1991; 164: 778-80.
23. Haase C, Büdinger L, Borradori L et al. Detection of IgG, autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2. J Invest Dermatol 1998; 110: 282-6.
24. Holmes RC, Black MM. Jurecka W et al. Clues to the aetiology and pathogenesis of herpes gestationis. Br J Dermatol 1983; 109: 131-9.